Activation of TLRs in NSCLC cells leads to upregulation of pro-inflammatory cytokines and chemokines (TNF-α or CCL2), contributing to the immunosuppressive nature of the tumor microenvironment [30,31,32,33,34,35,36]. The gene discussed is TNF; the disease is non-small cell lung carcinoma.